Comparison Different Methods of Intraoperative and Intraperitoneal Chemotherapy for Patients with Gastric Cancer: A Meta-analysis |
Huang, Jin-Yu
(Department of Surgical Oncology and General Surgery, First Hospital of China Medical University)
Xu, Ying-Ying (Department of Surgical Oncology and General Surgery, First Hospital of China Medical University) Sun, Zhe (Department of Surgical Oncology and General Surgery, First Hospital of China Medical University) Zhu, Zhi (Department of Surgical Oncology and General Surgery, First Hospital of China Medical University) Song, Yong-Xi (Department of Surgical Oncology and General Surgery, First Hospital of China Medical University) Guo, Peng-Tao (Department of Surgical Oncology and General Surgery, First Hospital of China Medical University) You, Yi (Department of Surgical Oncology and General Surgery, First Hospital of China Medical University) Xu, Hui-Mian (Department of Surgical Oncology and General Surgery, First Hospital of China Medical University) |
1 | Altman DG, Bland JM (2003). Interaction revisited: the difference between two estimates. BMJ, 326, 219. DOI |
2 | Brenner B, Shah MA, Karpeh MS et al (2006). A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol, 17, 1404-11. DOI |
3 | Coffey DS, Getzenberg RH, DeWeese TL (2006). Hyperthermic biology and cancer therapies: a hypothesis for the "Lance Armstrong effect. JAMA, 296, 445-8. DOI |
4 | Deng HJ, Wei ZG, Zhen L et al (2009). Clinical application of perioperative continuous hyperthermic peritoneal perfusion chemotherapy for gastric cancer. Nan Fang Yi Ke Da Xue Xue Bao, 29, 295-7. |
5 | Ding W, Duan D, Sun G, Gu C (2007). Clinical observation on early intraperitoneal hypertherm ic perfusion chemotherapy in the treatment of stomach carcinoma after operation. Tumor, 27, 585-7. |
6 | Ferlay J, Shin HR, Bray F et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. DOI |
7 | Fujimoto S, Takahashi M, Mutou T et al (1999). Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer, 85, 529-34. DOI |
8 | Gao Z, Jiang Z, Zhou F (2002). Clinical surgery of early intraperitoneal hyperthermic chemoperfusion for gastric cancer patients after operation. Zhonggou Zhongliu Linchuang, 29, 294-5. |
9 | Hildebrandt B, Wust P, Ahlers O et al (2002). The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol, 43, 33-56. DOI |
10 | Howell SB, Chu BB, Wung WE et al (1981). Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions. J Clin Invest, 67, 1161-70. DOI |
11 | Kuramoto M, Shimada S, Ikeshima S et al (2009). Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg, 250, 242-6. DOI |
12 | Matharu G, Tucker O, Alderson D (2011). Systematic review of intraperitoneal chemotherapy for gastric cancer. Br J Surg, 98, 1225-35. DOI |
13 | Paoletti X, Oba K, Burzykowski T et al (2010). Benefit of adjuvant chemotherapy for resectable gastric cancer: a metaanalysis. JAMA, 303, 1729-37. DOI |
14 | Nakao K, Otsuki Y, Akao Y et al (2000). The synergistic effects of hyperthermia and anticancer drugs on induction of apoptosis. Med Electron Microsc, 33, 44-50. DOI |
15 | Newman E, Potmesil M, Ryan T et al (2005). Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study. Semin Oncol, 32, S97-100. DOI |
16 | Ohtsu A, Yoshida S, Saijo N (2006). Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol, 24, 2188-96. DOI |
17 | Parmar MK, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 17, 2815-34. DOI |
18 | Ravichandran D, Lamah M, Carty NJ, Johnson CD (1995). Extended lymph node dissection (D2 resection) should now be performed routinely in the curative surgical treatment of gastric carcinoma. Ann R Coll Surg Engl, 77, 431-6. DOI |
19 | Roder JD, Bonenkamp JJ, Craven J et al (1995). Lymphadenectomy for gastric cancer in clinical trials: update. World J Surg, 19, 546-53. DOI |
20 | Rosen HR, Jatzko G, Repse S et al (1998). Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology. J Clin Oncol, 16, 2733-8. DOI |
21 | Roti Roti JL (2008). Cellular responses to hyperthermia (40- 46 degrees C): cell killing and molecular events. Int J Hyperthermia, 24, 3-15. DOI |
22 | Tierney JF, Stewart LA, Ghersi D et al (2007). Practical methods for incorporating summary time-to-event data into metaanalysis. Trials, 8, 16. DOI ScienceOn |
23 | Shimoyama S, Shimizu N, Kaminishi M (1999). Type-oriented intraoperative and adjuvant chemotherapy and survival after curative resection of advanced gastric cancer. World J Surg, 23, 284-91; discussion 91-2. DOI |
24 | Speyer JL, Sugarbaker PH, Collins JM et al (1981). Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res, 41, 1916-22. DOI |
25 | Takahashi T, Hagiwara A, Shimotsuma M et al (1995). Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles. World J Surg, 19, 565-9. DOI ScienceOn |
26 | Wei G, Fang GE, Bi JW et al (2005a). Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer. Ai Zheng, 24, 478-82. DOI ScienceOn |
27 | Wei G, Fang GE, Bi JW et al (2005b). [Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer]. Ai Zheng, 24, 478-82. |
28 | Yan TD, Black D, Sugarbaker PH et al (2007). A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol, 14, 2702-13. DOI |
29 | Yang XJ, Huang CQ, Suo T et al (2011). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol, 18, 1575-81. DOI |
30 | Yonemura Y, de Aretxabala X, Fujimura T et al (2001). Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology, 48, 1776-82. DOI |
31 | Yu W, Whang I, Chung HY et al (2001). Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg, 25, 985-90. DOI ScienceOn |
32 | Zhang GY, Chen XC, Pan K et al (2007). Application of hyperthermic intraoperative intraperitoneal chemotherapy in patients with gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi, 10, 362-4. DOI ScienceOn |
33 | Zhang W, Su D, WANG K et al (1998). Clinical study in prophylactic use of intraperitoneal hyperthermic chemoperfusion for the prevention of peritoneal metastasis in patients with advanced gastric carcinoma. Shanxi Yiyao Zazhi, 27, 67-9. |
34 | Zuo Y, Xu M, Shen D et al (2004). Postoperative intraperitioneal hyperthermic chemoperfusion combined with intravenous chemotherapy for 82 advanced gastric cancer patients. Zhonghua Zhong Liu Za Zhi, 26, 247-9. |